Compare NFE & ITOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | NFE | ITOC |
|---|---|---|
| Founded | 2014 | 1998 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Oil/Gas Transmission | |
| Sector | Utilities | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.6M | 28.1M |
| IPO Year | 2018 | 2023 |
| Metric | NFE | ITOC |
|---|---|---|
| Price | $3.45 | $2.80 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 413.9K | 58.7K |
| Earning Date | 11-20-2026 | 03-19-2027 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,504,037,000.00 | N/A |
| Revenue This Year | $108.26 | N/A |
| Revenue Next Year | $3.52 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.23 | $0.22 |
| 52 Week High | $16.90 | $4.49 |
| Indicator | NFE | ITOC |
|---|---|---|
| Relative Strength Index (RSI) | 40.06 | 56.73 |
| Support Level | $0.40 | $0.27 |
| Resistance Level | $7.13 | $4.49 |
| Average True Range (ATR) | 0.41 | 0.50 |
| MACD | -0.25 | -0.10 |
| Stochastic Oscillator | 3.42 | 10.67 |
New Fortress Energy Inc is an integrated gas-to-power company. It owns and operates natural gas and liquefied natural gas (LNG) infrastructure, and an integrated fleet of ships and logistics assets to deliver turnkey energy solutions to markets globally. The company's reportable segments are: Terminals and Infrastructure, and Ships. Maximum revenue is generated from the Terminals and Infrastructure segment, which includes vertically integrated gas-to-power solutions, spanning the entire production and delivery chain from natural gas procurement and liquefaction to logistics, shipping, facilities, and conversion or development of natural gas-fired power generation. Vessels that are utilized in the company's terminal, logistics, or sub-charter operations are included in this segment.
iTonic Holdings Ltd through its subsidiary, focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its product, Beijing Feitian's Treatment Planning System, helps ensure safe and effective brachytherapy using radioactive sources inside the patient to kill cancer cells and shrink tumors. Its product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device, etc.